Evidence map›Paper›PMID 40518491›Full record

ArticleJournal of clinical immunology2025

NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 Patients.

Sara Signa, Martina Bartolucci, Martina Bonacini, Arinna Bertoni, Genny Del Zotto, Anna Corcione, Andrea Petretto, Silvia Della Bella, Roberta Bertelli, Dario Di Silvestre and 17 more

Abstract read
In one paragraph

Article in Journal of clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Sara SignaUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Martina BartolucciCore Facilities-Clinical Proteomics and Metabolomics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Martina BonaciniClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Arinna BertoniUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Genny Del ZottoCore Facilities Flow-Cytometry, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Anna CorcioneUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Andrea PetrettoCore Facilities-Clinical Proteomics and Metabolomics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Silvia Della BellaUnit of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Roberta BertelliLaboratory of Human Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Dario Di SilvestreBiomedical Sciences, Institute for Biomedical Technologies National Research Counsil (ITB-CNR), Segrate, MI, Italy.
Andrea LomagnoBiomedical Sciences, Institute for Biomedical Technologies National Research Counsil (ITB-CNR), Segrate, MI, Italy.
Pierluigi MauriBiomedical Sciences, Institute for Biomedical Technologies National Research Counsil (ITB-CNR), Segrate, MI, Italy.
Roberta CaorsiUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Maurizio BruschiLaboratory of Molecular Nephrology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Simone BalinDepartment of Medical Biotechnologies and Translational Medicine (BioMeTra), University of Milan, Milan, Italy.
Paola BoccaUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Stefano VolpiUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Maria Grazia CatanosoClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Alessia CafaroUnit of Biochemistry, Pharmacology and Newborn Screening, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Gino TripodiServizio Di Immunoematologia E Medicina Trasfusionale, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Lorenzo PellottieriDipartimento Di Medicina Sperimentale (DIMES), Università of Genova, Genoa, Italy.
Domenico MavilioUnit of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy.
Antonella InsalacoDivision of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Stefania CrociClinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Carlo SalvaraniUnità Operativa Complessa Di Reumatologia, Azienda USL IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Marco GattornoUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy. marcogattorno@gaslini.org.
Francesca SchenaUOC Reumatologia E Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy. francescaschena@gaslini.org.

Funding

Ministero della Salute 5M-2018- 23680427Ministero della Salute 5M-2019-23680417Ministero della Salute RF-2019-12370600
6 · The paper itself

Abstract

purposeAdenosine deaminase 2 Deficiency (DADA2) is an autoinflammatory disease characterized by systemic vasculopathy, strokes and mild immunodeficiency. Recently NETosis has been implicated in the pathogenesis of Deficiency of Adenosine Deaminase 2. To deep investigate the possible effects of NETs on the immune system we characterized proteomic profile of NETs from DADA2 as compared to HD and Polyarteritis Nodosa (PAN) patients. To determine if NETs contain possibly immunogenic antigens we study functional aspects on Dendritic Cells after in vitro stimulation with NETs.

methodsTwenty-three DADA2 patients were enrolled. We analyzed NETosis by Imaging Flow Citometry. We evaluated NETs remnants and DNAse in the plasma samples by ELISA assay whereas DNAse activity by DNA digestion. We used quantitative proteomics approach and network analysis to identify NET proteins and pathways in 6 DADA2, 7 PAN and 7 HD. We analyzed circulating and monocyte-derived dendritic cells by flow cytometry.

resultsNeutrophils from DADA2 patients show a significant increased suicidal NETosis. DNAse enzymes were not normal in the level or activity. By proteomic analysis we identified 1356 proteins among which a hundred of proteins were significantly up or down-modulated in DADA2 NETs as compared to normal and disease control NETs in resting condition and after stimulation with PMA, Adenosine and TNFα. DADA2 NETs are significantly more efficient than normal NETs in stimulating patients' monocyte-derived dendritic cells.

conclusionWe identified different pathways significantly modulated in DADA2 NETs versus PAN/HD NETs. This peculiar protein profile could contribute in activating inflammatory pathways in Dendritic cells in DADA2.

Indexed as

Adenosine DeaminaseDendritic CellsExtracellular TrapsInflammationAdultFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedNeutrophilsProteomeProteomicsSignal TransductionYoung AdultADA2 protein, humanAdenosine DeaminaseIntercellular Signaling Peptides and ProteinsProteomeDADA2InflammationNeutrophil extracellular trapsPANProteomic

Identifiers

PMID40518491
PMCPMC12167720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.